Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition has called its 33rd AGM on Friday, September 26, 2025, at 10:30 a.m. through video conferencing, with three items on the agenda. The first is the adoption of the audited financial statements for the financial year ended March 31, 2025, along with the Board's and Auditors' reports. The second is the re-appointment of Dr. Anuradha Srinivasa Raghavan (DIN: 06557718), who retires by rotation. The third is a special resolution to approve the remuneration of Managing Director Mr. Srinivasa Raghavan Mathurakavi Ayyangar (DIN: 00090266) in the scale of Rs. 2,00,000 to Rs. 3,00,000 per month from FY 2025-26 onwards. The notice has been filed with BSE under SEBI LODR Regulation 34.
Routine AGM notice with no major surprises; shareholders should note that the MD remuneration proposal requires approval by a special resolution (higher 75% majority), which is the most notable voting item at this meeting.